23 October 2017

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology has been notified that Rachael Hawken, a person discharging managerial responsibilities ("PDMR"), has purchased 19,581 shares of 0.2p each in the Company ("Ordinary Shares") into her Self-Invested Personal Pension ("SIPP").

Further details are contained within the notification below, made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.


For further information please contact:

Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
+44 (0) 1483 685 670

Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong
Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Mark Court / Sophie Wills /
Stephanie Watson / Tilly Abraham
Tel: +44 (0) 20 7466 5000


Notes to Editors

About Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.



Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Rachael Hawken
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 0.2p each
  Identification code GB0033278473
b) Nature of the transactions Transfer of shares to SIPP through purchase by SIPP
c) Prices and volumes
Price(s) Volume(s)
(i) 24.145 pence (i) 9,268
(ii) 24.125 pence (ii) 10,313
d) Aggregated information  
  - Aggregated volume 19,581 ordinary shares of 0.2p each
  - Price 24.13447 pence
e) Date of the transactions (i) 18 October 2017
(ii) 23 October 2017
f) Place of the transactions (i) XLON
(ii) XLON